U.S. pharma large copyright scrapped two experimental weight loss products final 12 months—a once-everyday capsule, lotiglipron, as a result of elevated liver enzymes and a twice-day-to-day tablet, danuglipron, on account of powerful side effects—but CEO Albert Bourla has claimed the company is decided to “Enjoy and acquire” inside the obes